Exploring the Impact of Modifiable Factors on Serum BDNF in Psychiatric Patients and Community Controls
Galen Chan,1 Tea Rosic,2,3 Stanislav Pasyk,2 Mahshid Dehghan,4 Zainab Samaan2,3 1Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada; 2Department of Psychiatry and Behavioral Neurosciences, McMaster University, Hamilton, Ontario, Canada; 3Department of Health Resea...
Main Authors: | Chan G, Rosic T, Pasyk S, Dehghan M, Samaan Z |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-02-01
|
Series: | Neuropsychiatric Disease and Treatment |
Subjects: | |
Online Access: | https://www.dovepress.com/exploring-the-impact-of-modifiable-factors-on-serum-bdnf-in-psychiatri-peer-reviewed-article-NDT |
Similar Items
-
Evaluation of BDNF as a Biomarker for Impulsivity in a Psychiatric Population
by: Stanislav Pasyk, et al.
Published: (2020-06-01) -
A tale of two maladies? Pathogenesis of depression with and without the Huntington’s disease gene mutation
by: Xin eDu, et al.
Published: (2013-07-01) -
Mice with altered BDNF signaling as models for mood disorders and antidepressant effects
by: Jesse Saku Olavi Lindholm, et al.
Published: (2014-04-01) -
The Role of BDNF in the Neuroimmune Axis Regulation of Mood Disorders
by: Yang Jin, et al.
Published: (2019-06-01) -
Molecular Pathways Bridging Frontotemporal Lobar Degeneration and Psychiatric Disorders
by: Roberta eZanardini, et al.
Published: (2016-02-01)